Duaklir Pressair: another LAMA/LABA inhaler for COPD

Med Lett Drugs Ther. 2019 Sep 23;61(1581):149-151.
No abstract available

Keywords: Anoro Ellipta; Bevespi Aerosphere; COPD; Chronic obstructive pulmonary disease; Duaklir Pressair; Inspiolto Respimat; LABA; LAMA; Stiolto Respimat; Ultibro Breezehaler; Utibron Neohaler; aclidinium; adverse effects; dosage; drug interactions; efficacy; formoterol; glycopyrrolate; indacaterol; lactation; long-acting beta2-agonists; pregnancy; safety; tiotropium/olodaterol; umeclidinium; vilanterol.

Publication types

  • Review

MeSH terms

  • Administration, Inhalation
  • Adrenergic beta-Agonists / administration & dosage*
  • Adrenergic beta-Agonists / pharmacokinetics
  • Bronchodilator Agents / administration & dosage*
  • Bronchodilator Agents / pharmacokinetics
  • Drug Combinations
  • Humans
  • Muscarinic Antagonists / administration & dosage*
  • Muscarinic Antagonists / pharmacokinetics
  • Nebulizers and Vaporizers
  • Pulmonary Disease, Chronic Obstructive / drug therapy*
  • Pulmonary Disease, Chronic Obstructive / metabolism
  • Randomized Controlled Trials as Topic / methods

Substances

  • Adrenergic beta-Agonists
  • Bronchodilator Agents
  • Drug Combinations
  • Muscarinic Antagonists